Epimorphin-/- mice are protected, in part, from acute colitis via decreased interleukin 6 signaling

Translational Research

Volumn 164, Issue 1, 2014, Pages 70-83

  Shaker, Anisa ^a   Gargus, Matthew ^a   Fink, Julie ^b   Binkley, Jana ^b   Darwech, Isra ^b   Swietlicki, Elzbieta ^b   Levin, Marc S ^b,c   Rubin, Deborah C ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA St Louis Health Care System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DEXTRAN SULFATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; STAT3 PROTEIN; SYNTAXIN 2; TUBULIN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY COMBINING SITE; ARTICLE; CELL POPULATION; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DESCENDING COLON; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES COMPOSITION; GENE SILENCING; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MORBIDITY; MOUSE; MYOFIBROBLAST; NONHUMAN; PERITONEUM MACROPHAGE; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; RECTUM HEMORRHAGE; SIGNAL TRANSDUCTION; STROMA; WEIGHT REDUCTION;

ANIMALS; COLITIS; DEXTRAN SULFATE; GENE EXPRESSION REGULATION; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 84902539173     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.03.007     Document Type: Article

References (43)

1. D.C. Rubin, A. Shaker, and M.S. Levin Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer Front Immunol 3 2012 107
2. G. Bouguen, J.B. Chevaux, and L. Peyrin-Biroulet Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases World J Gastroenterol 17 2011 547 556
3. F. Sanchez-Munoz, A. Dominguez-Lopez, and J.K. Yamamoto-Furusho Role of cytokines in inflammatory bowel disease World J Gastroenterol 14 2008 4280 4288
4. S.Y. Salim, and J.D. Soderholm Importance of disrupted intestinal barrier in inflammatory bowel diseases Inflamm Bowel Dis 17 2011 362 381
5. D.W. Powell, R.C. Mifflin, and J.D. Valentich et al. Myofibroblasts: II. Intestinal subepithelial myofibroblasts Am J Physiol 277 1999 C183 C201
6. A. Andoh, S. Fujino, and T. Okuno et al. Intestinal subepithelial myofibroblasts in inflammatory bowel diseases J Gastroenterol 37 2002 33 37
7. M. Brittan, V. Chance, and G. Elia et al. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts Gastroenterology 128 2005 1984 1995
8. I.V. Pinchuk, R.C. Mifflin, and J.I. Saada et al. Intestinal mesenchymal cells Curr Gastroenterol Rep 12 2010 310 318
9. I.V. Pinchuk, E.J. Beswick, and J.I. Saada et al. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells Gastroenterology 140 2011 2019 2030
10. J.E. Rothman Mechanisms of intracellular protein transport Nature 372 1994 55 63
11. C. Fritsch, E.A. Swietlicki, and O. Lefebvre et al. Epimorphin expression in intestinal myofibroblasts induces epithelial morphogenesis J Clin Invest 110 2002 1629 1641
12. A. Goyal, R. Singh, and E.A. Swietlicki et al. Characterization of rat epimorphin/syntaxin 2 expression suggests a role in crypt-villus morphogenesis Am J Physiol 275 1998 G114 G124
13. Y. Wang, L. Wang, and H. Iordanov et al. Epimorphin(-/-) mice have increased intestinal growth, decreased susceptibility to dextran sodium sulfate colitis, and impaired spermatogenesis J Clin Invest 116 2006 1535 1546
14. A. Mizoguchi Animal models of inflammatory bowel disease Prog Mol Biol Transl Sci 105 2012 263 320
15. S. Melgar, A. Karlsson, and E. Michaelsson Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation Am J Physiol Gastrointest Liver Physiol 288 2005 G1328 G1338
16. A. Shaker, E.A. Swietlicki, and L. Wang et al. Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion J Clin Invest 120 2010 2081 2093
17. Y. Li, C. Yu, and W.M. Zhu et al. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17 Mol Immunol 47 2010 2467 2474
18. J. Mudter, and M.F. Neurath IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance Inflamm Bowel Dis 13 2007 1016 1023
19. V. Valatas, M. Vakas, and G. Kolios The value of experimental models of colitis in predicting efficacy of biologic therapies for inflammatory bowel diseases Am J Physiol Gastrointest Liver Physiol 305 2013 G763-G785
20. F. Loher, K. Schmall, and P. Freytag et al. The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice J Pharmacol Exp Ther 305 2003 549 556
21. S.N. Murthy, H.S. Cooper, and H. Shim et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin Dig Dis Sci 38 1993 1722 1734
22. R.D. Newberry, W.F. Stenson, and R.G. Lorenz Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen Nat Med 5 1999 900 906
23. M. Coccia, O.J. Harrison, and C. Schiering et al. IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells J Exp Med 209 2012 1595 1609
24. B. Siegmund, H.A. Lehr, and G. Fantuzzi et al. IL-1 beta-converting enzyme (caspase-1) in intestinal inflammation Proc Natl Acad Sci U S A 98 2001 13249 13254
25. B. Hoang, A. Trinh, and L. Birnbaumer et al. Decreased MAPK- and PGE2-dependent IL-11 production in Gialpha2-/- colonic myofibroblasts Am J Physiol Gastrointest Liver Physiol 292 2007 G1511 G1519
26. S. Wirtz, and M.F. Neurath Mouse models of inflammatory bowel disease Adv Drug Deliv Rev 59 2007 1073 1083
27. H.J. Hugo, S. Lebret, and E. Tomaskovic-Crook et al. Contribution of fibroblast and mast cell (afferent) and tumor (efferent) IL-6 effects within the tumor microenvironment Cancer Microenviron 5 2012 83 93
28. M.J. Lee, J.K. Lee, and J.W. Choi et al. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis PLoS One 7 2012 e38801
29. Y. Naito, T. Takagi, and K. Uchiyama et al. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice Int J Mol Med 14 2004 191 196
30. C. Neufert, G. Pickert, and Y. Zheng et al. Activation of epithelial STAT3 regulates intestinal homeostasis Cell Cycle 9 2010 652 655
31. T.A. Willson, I. Jurickova, and M. Collins et al. Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice Inflamm Bowel Dis 19 2013 512 525
32. N. Li, S.I. Grivennikov, and M. Karin The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment Cancer Cell 19 2011 429 431
33. H. Yu, M. Kortylewski, and D. Pardoll Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nat Rev Immunol 7 2007 41 51
34. J. Mudter, and M.F. Neurath Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications Gut 56 2007 293 303
35. A. Shukla, L. Berglund, and L.P. Nielsen et al. Regulated exocytosis in immune function: are SNARE-proteins involved? Respir Med 94 2000 10 17
36. A. Andou, T. Hisamatsu, and S. Okamoto et al. Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages Gastroenterology 136 2009 564 574
37. I. Kure, S. Nishiumi, and Y. Nishitani et al. Lipoxin A4 reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of NF-{kappa}B activation J Pharmacol Exp Ther 332 2009 541 548
38. E.E. Ghosn, A.A. Cassado, and G.R. Govoni et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets Proc Natl Acad Sci U S A 107 2010 2568 2573
39. T. Shirasaka, M. Iizuka, and M. Yukawa et al. Altered expression of epimorphin in ulcerative colitis J Gastroenterol Hepatol 18 2003 570 577
40. A. Andoh, S. Fujino, and Y. Hirai et al. Epimorphin expression in human colonic myofibroblasts Int J Mol Med 13 2004 57 61
41. M. Yamada, T. Oda, and K. Higashi et al. Involvement of epimorphin in the repair of experimental renal fibrosis in mice Lab Invest 90 2010 867 880
42. M. Brittan, T. Hunt, and R. Jeffery et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon Gut 50 2002 752 757
43. Y. Nemoto, T. Kanai, and M. Takahara et al. Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells Gut 62 2013 1142 1152